News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agilent Technologies, Inc. (Santa Clara, California) (A) Expands HaloPlex Target Enrichment for Ion Torrent Next-Generation Sequencers



6/4/2012 12:42:26 PM

SANTA CLARA, Calif., June 4, 2012 – Agilent Technologies Inc. (NYSE: A) today announced the expansion of the HaloPlex target enrichment system, which will now be available on Ion Torrent’s Personal Genome Machine, a benchtop sequencing solution.

The HaloPlex system features a unique paired-end design, which positions reads at both target ends using a single-end sequencing run. By taking advantage of the extra coverage that the paired-end design provides, researchers will be able to save sequencing costs and time.

“The HaloPlex technology makes it possible for us to capture specific sets of genes in a single reaction,” said Peter Ray, head of molecular genetics at The Hospital for Sick Children in Toronto, Canada. “So far we have gotten great coverage of the mutations we were looking for. By combining HaloPlex with Ion Torrent we are able to generate sequencing data for our targets in a single day.”

HaloPlex continues to break barriers common to other target enrichment technologies and can now enable larger capture sizes during desktop sequencing – up to 5Mb or approximately 2,000 genes on a MiSeq personal sequencer. HaloPlex offers greater efficiency and improved performance and, with the update released today, it allows researchers to process up to 250,000 amplicons in the same tube.

“HaloPlex is helping to transform target enrichment, especially for desktop sequencers,” said Olle Ericsson, director of marketing, DNA sequencing at Agilent. “We are overcoming previous barriers with the fastest, most flexible and most innovative target enrichment platform on the market.”

The Haloplex system’s fast-scaling target enrichment technology demonstrates Agilent’s ongoing commitment to enabling a better research workflow regardless of the sequencer platform being used.

HaloPlex is a flexible and customizable product that enables users to create designs in less than 10 minutes to enrich thousands of genomic targets, using the no-charge Web Design Wizard.

Agilent acquired Halo Genomics of Uppsala, Sweden, and the HaloPlex platform in December, 2011. HaloPlex technology complements the existing Agilent SureSelect target-enrichment system.

For more information, visit www.agilent.com/genomics/ngs.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,700 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES